22 February 2021 in Critical Reviews in Biochemistry and Molecular Biology
Organisms from all domains of life invest a substantial amount of energy for the introduction of RNA modifications into nearly all transcripts studied to date. Instrumental analysis of RNA can focus on the modified residues and reveal the function of these epitranscriptomic marks. Here, we will review recent advances and breakthroughs achieved by NMR spectroscopy, sequencing, and mass spectrometry of the epitranscriptome. Graphical Abstract
31 August 2023 in Nucleic Acids Research
As essential components of the protein synthesis machinery, tRNAs undergo a tightly controlled biogenesis process, which include the incorporation of numerous posttranscriptional modifications. Defects in these tRNA maturation steps may lead to the degradation of hypomodified tRNAs by the rapid tRNA decay (RTD) and nuclear surveillance pathways. We previously identified m1A58 as a late modification introduced after modifications Ψ55 and T54 in yeast elongator tRNAPhe. However, previous reports suggested that m1A58 is introduced early during the tRNA modification process, in particular on primary transcripts of initiator tRNAiMet, which prevents its degradation by RNA decay pathways. Here, aiming to reconcile this apparent inconsistency on the temporality of m1A58 incorporation, we examined its introduction into yeast elongator and initiator tRNAs. We used specifically modified tRNAs to report on the molecular aspects controlling the Ψ55 → T54 → m1A58 modification circuit in elongator tRNAs. We also show that m1A58 is efficiently introduced on unmodified tRNAiMet, and does not depend on prior modifications. Finally, we show that m1A58 has major effects on the structural properties of initiator tRNAiMet, so that the tRNA elbow structure is only properly assembled when this modification is present. This observation provides a structural explanation for the degradation of hypomodified tRNAiMet lacking m1A58 by the nuclear surveillance and RTD pathways.
2 August 2021 in Angewandte Chemie International Edition
In this report, we perform structure validation of recently reported RNA phosphorothioate (PT) modifications, a new set of epitranscriptome marks found in bacteria and eukaryotes including humans. By comparing synthetic PT‐containing diribonucleotides with native species in RNA hydrolysates by high‐resolution mass spectrometry (MS), metabolic stable isotope labeling, and PT‐specific iodine‐desulfurization, we disprove the existence of PTs in RNA from E. coli, S. cerevisiae, human cell lines, and mouse brain. Furthermore, we discuss how an MS artifact led to the initial misidentification of 2′‐O‐methylated diribonucleotides as RNA phosphorothioates. To aid structure validation of new nucleic acid modifications, we present a detailed guideline for MS analysis of RNA hydrolysates, emphasizing how the chosen RNA hydrolysis protocol can be a decisive factor in discovering and quantifying RNA modifications in biological samples.
2 August 2021 in Angewandte Chemie
In diesem Artikel führen wir eine Strukturvalidierung von RNA‐Phosphorothioat (PT)‐Modifikationen durch, von welchen vor Kurzem im Epitranskriptom von Bakterien und Eukaryoten, einschließlich des Menschen, berichtet wurde. Durch den Vergleich synthetischer PT‐haltiger Diribonukleotide mit nativen Spezies aus RNA‐Hydrolysaten mittels hochauflösender Massenspektrometrie (MS), metabolisch stabiler Isotopenmarkierung und PT‐spezifischer Iodoxidation, widerlegen wir die Existenz von PTs in RNA aus E. coli, S. cerevisiae, menschlichen Zelllinien und Mausgehirn. Darüber hinaus erläutern wir, wie 2′‐O‐methylierte Diribonukleotide durch ein MS‐Artefakt anfänglich als RNA‐Phosphorothioate fehlidentifiziert wurden. Um die Strukturvalidierung neuer Nukleinsäuremodifikationen zu unterstützen, präsentieren wir einen detaillierten Leitfaden für die MS‐Analyse von RNA‐Hydrolysaten und betonen, wie das gewählte RNA‐Verdauprotokoll ein entscheidender Faktor bei der Entdeckung und Quantifizierung von RNA‐Modifikationen in biologischen Proben sein kann.
16 December 2022 in bioRxiv
As essential components of the cellular protein synthesis machineries, tRNAs undergo a tightly controlled biogenesis process, which include the incorporation of a large number of posttranscriptional chemical modifications. Maturation defaults resulting in lack of modifications in the tRNA core may lead to the degradation of hypomodified tRNAs by the rapid tRNA decay (RTD) and nuclear surveillance pathways. Although modifications are typically introduced in tRNAs independently of each other, several modification circuits have been identified in which one or more modifications stimulate or repress the incorporation of others. We previously identified m 1 A58 as a late modification introduced after more initial modifications, such as Ѱ55 and T54 in yeast elongator tRNA Phe . However, previous reports suggested that m 1 A58 is introduced early along the tRNA modification process, with m 1 A58 being introduced on initial transcripts of initiator tRNA i Met , and hence preventing its degradation by the nuclear surveillance and RTD pathways. Here, aiming to reconcile this apparent inconsistency on the temporality of m 1 A58 incorporation, we examined the m 1 A58 modification pathways in yeast elongator and initiator tRNAs. For that, we first implemented a generic approach enabling the preparation of tRNAs containing specific modifications. We then used these specifically modified tRNAs to demonstrate that the incorporation of T54 in tRNA Phe is directly stimulated by Ѱ55, and that the incorporation of m 1 A58 is directly and individually stimulated by Ѱ55 and T54, thereby reporting on the molecular aspects controlling the Ѱ55 → T54 → m 1 A58 modification circuit in yeast elongator tRNAs. We also show that m 1 A58 is efficiently introduced on unmodified tRNA i Met , and does not depend on prior modifications. Finally, we show that the m 1 A58 single modification has tremendous effects on the structural properties of yeast tRNA i Met , with the tRNA elbow structure being properly assembled only when this modification is present. This rationalizes on structural grounds the degradation of hypomodified tRNA i Met lacking m 1 A58 by the nuclear surveillance and RTD pathways.